Flu Vaccination Linked to 40% Lower Risk of Alzheimer’s Disease
Over the course of four years, those who received at least one influenza vaccine were 40% less likely than their non-vaccinated peers to acquire Alzheimer’s…
Vaccine
New Research: COVID-19 Vaccines Saved 20 Million Lives Worldwide in the First Year
First modeling study to quantify the impact of COVID-19 vaccines on a global scale estimates that 19.8 million out of a potential 31.4 million deaths…
COVID Vaccine-Related Swelling Lasts Longer Than Initially Reported
The duration of axillary lymphadenopathy detected by breast ultrasound after COVID-19 mRNA vaccination is longer than previously reported in initial vaccine clinical trials. A new…
New Strategy Discovered To Potentially Reduce Fatigue After COVID-19 Vaccination
Mouse experiments suggest a switch from intramuscular to subcutaneous injection may ease fatigue. Currently, mRNA-based COVID-19 vaccines are injected deep into the muscles, which is…
Why We Can’t “Boost” Our Way Out of the COVID-19 Pandemic
You may be wondering whether the long-term plans for the COVID-19 pandemic call for an endless number of booster shots. They do provide a boost…
Study Shines Light on Immune Responses for Long-Lasting Protection From COVID-19
By uniting research from 8 cohorts across the United States, a group of researchers has accelerated the collection of data integral in answering questions about…
MIT Expert on the Progress of mRNA Vaccines
Following the successful development of Covid-19 vaccines, researchers hope to deploy mRNA-based therapies to combat many other diseases. Two mRNA vaccines, which were granted emergency…
mRNA COVID-19 Vaccines – Like Pfizer and Moderna – Work Better Against Variants of Concern
A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines — Pfizer-BioNTech and Moderna — perform better against the World Health Organization (WHO)’s…
National Institutes of Health Launches Clinical Trial of Epstein-Barr Virus Vaccine
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an early-stage clinical trial to evaluate…
COVID-19 Vaccines May Be Significantly Less Effective in People With Severe Obesity
Study suggests severe obesity blunts antibody response to COVID-19 vaccines. Pfizer/BioNTech linked to a more robust antibody response than CoronaVac in people with severe obesity….
Why the 100-Year-Old BCG Tuberculosis Vaccine Is So Broadly Protective Against Infections in Newborns
Researchers discover changes in metabolite and lipid profiles, providing clues for designing future vaccines for newborns. The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is…
COVID-19 mRNA Vaccine Technique Shows Promise for Treating Heart Disease
A technique for delivering genetic material to the body is being investigated as a means of repairing damaged heart muscle after a heart attack. The…
Mix-and-Match Approach to Booster Vaccination Offers the Best Protection Against COVID-19
A new study on Chile’s national COVID-19 vaccination program, being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon,…
COVID-19 Third Dose Vaccine Protection Against Hospitalization Wanes After 3 Months
Kaiser Permanente finds the Pfizer COVID-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months. A research study released on April 22,…
Longer Interval Between COVID-19 Vaccines Generates Up to 9x As Many Protective Antibodies
New research has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold. The study will be presented…
Fully Vaccinated and Boosted Woman Catches COVID Omicron Infection Just 20 Days After Delta
A fully vaccinated and boosted 31-year-old woman tested positive for Omicron strain of SARS-CoV-2 just 20 days after having Delta infection. Researchers in Spain provide…
COVID-19 Infection Granted Unvaccinated People Strong, Long-Lasting Protection on Par With mRNA Vaccines
Researchers looked at COVID-19 immunity prior to emergence of the omicron variant to help inform vaccine and infection control policy. A study released in JAMA…
Newly Developed COVID Vaccine Could Protect Against Omicron and Other Variants
Vaccine developed at MedUni Vienna delivers promising data. The preclinical data for a vaccine developed at MedUni Vienna to protect against SARS-CoV-2 indicates that it…
